POP SINGER Pilot Study (POP SINGER 1)

September 1, 2026 updated by: Angelique Foss, University Hospitals Cleveland Medical Center

Pain Management Optimized Through Patient-centered Multi-Session Group Music Therapy Within INteGrative sharEd progRamming: A Single-arm Pilot Study

Conduct a single-arm pilot study (N = 24) to examine the feasibility and acceptability of the hybrid (i.e., half in-person, half online) POPSINGER group Music Therapy (MT) intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Ohio
      • Cleveland, Ohio, United States, 44106
        • University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults age 18 and older
  • Reporting pain on most days per month for a duration of ≥3 months
  • Independently ambulatory
  • Willing to participate in full scope of program
  • Access to internet, active email address, & laptop, tablet, and/or PC with videoconferencing capabilities
  • Have reliable access to a mobile device with an active data plan at home and is comfortable accessing the internet and their email with this device
  • Able to read and understand English

Exclusion Criteria:

  • Significant hearing and/or visual impairment
  • Have had a major surgery (e.g., spine surgery, joint replacement) within the past 6 months
  • Have a planned surgery within the next 6 months at the time of enrollment
  • Unable to independently provide consent (i.e., no proxy consent)
  • Active suicidal ideation
  • Severe psychological comorbidity (e.g., psychosis, schizophrenia) that would prevent patient from engaging fully in intervention
  • Receiving active cancer treatment
  • Diagnosed with medical condition likely to be terminal within 24 weeks
  • Active substance abuse diagnosis in EHR
  • Currently receiving music therapy from a professional music therapist

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Music Therapy
A board-certified music therapist will provide a total of 16 MT sessions (8 in-person and 8 virtual) that include education, social connection, and experiential music interventions. These sessions will focus on self-management of pain through evidenced-based MT interventions including music sharing, playlists using the iso-principle, music making, music and guided imagery, music and deep breathing, progressive muscle relaxation, and adapted cardio drumming.
Behavioral: Music Therapy
A board-certified music therapist will provide a total of 16 MT sessions (8 in-person and 8 virtual) that include education, social connection, and experiential music interventions. These sessions will focus on self-management of pain through evidenced-based MT interventions including music sharing, playlists using the iso-principle, music making, music and guided imagery, music and deep breathing, progressive muscle relaxation, and adapted cardio drumming.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants retained as measured by enrollment logs
Time Frame: 8 weeks from the first music therapy intervention
A retention rate of ≥70% of recruited participants until the final survey time point.
8 weeks from the first music therapy intervention
Number of sessions attended per participant as measured by attendance logs
Time Frame: 8 weeks from the first music therapy intervention
An attendance rate of ≥11/16 sessions among ≥70% of retained participants.
8 weeks from the first music therapy intervention
Number of participants completing follow-up measures as measured by data collection logs
Time Frame: 8 weeks from the first music therapy intervention
A measure completion rate of ≥70% of follow-up measures among retained participants.
8 weeks from the first music therapy intervention
Number of participants reporting daily music exercise use in REDCap exercise logs
Time Frame: 8 weeks from the first music therapy intervention
≥60% of retained MT participants reporting use of music exercises at least once every other day.
8 weeks from the first music therapy intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospitals Cleveland Medical Center

Collaborators

Kulas Foundation

Investigators

  • Principal Investigator: Angelique Foss, CHES®, NBC-HWC, LPMT, MT-BC, University Hospitals Cleveland Medical Center
  • Study Director: Samuel N Rodgers-Melnick, PhD, MPH, LPMT, MT-BC, University Hospitals Cleveland Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2026

Primary Completion (Actual)

July 8, 2026

Study Completion (Actual)

July 8, 2026

Study Registration Dates

First Submitted

February 26, 2026

First Submitted That Met QC Criteria

February 26, 2026

First Posted (Actual)

March 4, 2026

Study Record Updates

Last Update Posted (Actual)

September 4, 2026

Last Update Submitted That Met QC Criteria

September 1, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY20260037

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe